Literature DB >> 22257672

Dual inhibition of HER2 in breast cancer treatment.

Michael Gnant1, Guenther G Steger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22257672     DOI: 10.1016/S0140-6736(12)60068-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  1 in total

1.  Application of Tucatinib and Trastuzumab: Dual Anti HER2 Therapy Against HER2 Positive Breast Cancer.

Authors:  Sumanpreet Kaur; Rajasri Bhattacharyya; Dibyajyoti Banerjee; Jaya Shukla
Journal:  Indian J Clin Biochem       Date:  2019-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.